UCLA Professor to be Honored for Extraordinary Contributions in the Prevention of Lung Cancer

Wednesday, August 21, 2019

ProposalMasthead_0318-01-1.png


Contact:
Becky.Bunn@IASLC.org | 720-325-2946

Chris Martin
Cmartin@davidjamesgroup.com | 630.670.2745

UCLA Professor to be Honored for Extraordinary Contributions in the Prevention of Lung Cancer  

DENVER – Denise R. Aberle, MD, from the David Geffen School of Medicine at the University of California at Los Angeles, will be recognized by the International Association for the Study of Lung Cancer (IASLC) with the Joseph W. Cullen Prevention/Early Detection Award at the IASLC 2019 World Conference on Lung Cancer (WCLC) in Barcelona, Spain. The award honors Dr. Aberle for her lifetime achievement in the prevention of lung and other thoracic cancers.

Dr. Aberle has been Vice Chair for Research in Radiological Sciences in the David Geffen School of Medicine at UCLA for 19 years. Her current research focuses on characterizing indeterminate lung nodules and early lung cancers using semantic, quantitative and machine learning techniques in combination with clinical and molecular features.

She previously served as president of the Society of Thoracic Radiology at the American College of Radiology Imaging Network (ACRIN). She has also received many awards for her work in lung cancer early detection from the IASLC, the UCLA Clinical Translational Science Institute, the American Lung Association, ACRIN and more.

Dr. Aberle will be honored on Sept. 7, 2019 at the Opening Ceremony of the IASLC 2019 WCLC in Barcelona, Spain. The IASLC WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The WCLC will take place in Barcelona, Spain, Sept. 7-10, 2019. For more information on the IASLC WCLC, please visit https://wclc2019.iaslc.org/.

About the WCLC:

The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2019.iaslc.org.

About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. 

###

 


About the Author

Chris Martin, Vice President, Public Relations